115 related articles for article (PubMed ID: 15330332)
1. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
Erdenizmenli M; Yapar N; Sengönül A; Yüce A; Cakir N; Yulug N
J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332
[No Abstract] [Full Text] [Related]
2. Fusidic acid as a potential antistaphylococcal agent.
Nicholson J; Chew T; Smith S
N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
[No Abstract] [Full Text] [Related]
3. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
[TBL] [Abstract][Full Text] [Related]
4. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Reynaud AE; Espaze EP; Coste-Burel M; Richet H
Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
[TBL] [Abstract][Full Text] [Related]
5. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
Rennie RP
J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
[TBL] [Abstract][Full Text] [Related]
7. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
Tünger O; Arisoy A; Kurutepe S; Akçali S; Ozbakkaloğlu B
Int J Antimicrob Agents; 2001 Nov; 18(5):445-7. PubMed ID: 11711260
[No Abstract] [Full Text] [Related]
9. Fusidic acid resistance in Staphylococcus aureus isolates.
Brown EM; Thomas P
Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
[No Abstract] [Full Text] [Related]
10. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
Amirak ID; Li AK; Williams RJ; Noone P
J Infect; 1981 Mar; 3(1):50-8. PubMed ID: 6926536
[No Abstract] [Full Text] [Related]
11. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid.
Huebner J; Kropec A; Engels I; Daschner F
Chemotherapy; 1992; 38(4):206-10. PubMed ID: 1473358
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
15. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
16. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
Peeters KA; Mascini EM; Blok HE; Sanders CJ
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
[TBL] [Abstract][Full Text] [Related]
17. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
18. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
Lim KT; Teh CS; Yusof MY; Thong KL
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
[TBL] [Abstract][Full Text] [Related]
19. [Nasal carriage of Staphylococcus aureus in hospital personnel and the normal population and antibiotic resistance of the isolates].
Yazgi H; Ertek M; Ozbek A; Kadanali A
Mikrobiyol Bul; 2003; 37(2-3):137-42. PubMed ID: 14593895
[TBL] [Abstract][Full Text] [Related]
20. [Outburst of fusidic acid resistant Staphylococcus aureus].
Kanazaki H; Akiyama H; Kanamoto A; Abe Y; Yamada T; Arata J; Umemura S; Ikeda M
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):507-10. PubMed ID: 2614994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
